Trends in Lung Cancer Incidence Rates by Histological Type in 1975-2008: A Population-Based Study in Osaka, Japan

Fukuaki Lee Kinoshita, Yuri Ito, Tomio Nakayama, Fukuaki Lee Kinoshita, Yuri Ito, Tomio Nakayama

Abstract

Background: Monitoring trends in lung cancer incidence and mortality is important for the evaluation of cancer control activities. We investigated recent trends in age-standardized incidence rates by histological type of lung cancer in Osaka, Japan.

Methods: Cancer incidence data for 1975-2008 were obtained from the Osaka Cancer Registry. Lung cancer mortality data with population data in Osaka during 1975-2012 were obtained from vital statistics. We examined trends in age-standardized incidence and mortality rates for all histological types and age-standardized incidence rates by histological type and age group using a joinpoint regression model.

Results: The age-standardized incidence rate of lung cancer levelled off or slightly increased from 1975-2008, with an annual percentage change of 0.3% (95% confidence interval [CI], 0.1%-0.4%) for males and 1.1% (95% CI, 0.9%-1.3%) for females, and the mortality rate decreased by 0.9% (95% CI, 1.2%-0.7%) for males and 0.5% (95% CI, 0.8%-0.3%) for females. The incidence rates of squamous cell carcinoma (SQC) and small cell carcinoma (SMC) significantly decreased for both genders, whereas that of adenocarcinoma (ADC) significantly increased among almost all age groups in both genders.

Conclusions: The incidence rates of SQC and SMC decreased with the decline in smoking prevalence, which probably explains the change in trends in the incidence rates of lung cancer from the mid-1980s. However, the reason for the increase in ADC remains unclear. Therefore, trends in incidence rates of lung cancer should be carefully monitored, especially for ADC, and the associations between ADC and its possible risk factors should be studied.

Figures

Figure 1.. Trends in age-standardized incidence and…
Figure 1.. Trends in age-standardized incidence and mortality rates for lung cancer in Osaka, Japan from 1975 to 2008.
Figure 2.. Trends in age-standardized incidence rates…
Figure 2.. Trends in age-standardized incidence rates of lung cancer by histological type in Osaka, Japan 1975 to 2008. ADC, adenocarcinoma; SMC, small cell carcinoma; SQC, squamous cell carcinoma.

References

    1. Katanoda K, Matsuda T, Matsuda A, Shibata A, Nishino Y, Fujita M, et al. . An updated report of the trends in cancer incidence and mortality in Japan. Jpn J Clin Oncol. 2013;43:492–507. 10.1093/jjco/hyt038
    1. Ito Y, Ioka A, Nakayama T, Tsukuma H, Nakamura T. Comparison of trends in cancer incidence and mortality in osaka, Japan, using an age-period-cohort model. Asian Pac J Cancer Prev. 2011;12:879–88.
    1. Inoue M, Sawada N, Matsuda T, Iwasaki M, Sasazuki S, Shimazu T, et al. . Attributable causes of cancer in Japan in 2005-Systematic assessment to estimate current burden of cancer attributable to known preventable risk factors in Japan. Ann Oncol. 2012;23(5):1362–9. 10.1093/annonc/mdr437
    1. Katanoda K, Marugame T, Saika K, Satoh H, Tajima K, Suzuki T, et al. . Population attributable fraction of mortality associated with tobacco smoking in Japan: a pooled analysis of three large-scale cohort studies. J Epidemiol. 2008;18(6):251–64. 10.2188/jea.JE2007429
    1. Sobue T, Ajiki W, Tsukuma H, Oshima A, Hanai A, Fujimoto I. Trends of lung cancer incidence by histologic type: a population-based study in Osaka, Japan. Jpn J Cancer Res. 1999;90:6–15. 10.1111/j.1349-7006.1999.tb00659.x
    1. Toyoda Y, Nakayama T, Ioka A, Tsukuma H. Trends in lung cancer incidence by histological type in Osaka, Japan. Jpn J Clin Oncol. 2008;38(8):534–9. 10.1093/jjco/hyn072
    1. Yoshimi I, Ohshima A, Ajiki W, Tsukuma H, Sobue T. A comparison of trends in the incidence rate of lung cancer by histological type in the Osaka Cancer Registry, Japan and in the surveillance, epidemiology and end results program, USA. Jpn J Clin Oncol. 2003;33(2):98–104. 10.1093/jjco/hyg019
    1. Curado M, Edwards B, Shin H, et al. . Cancer incidence in five continents. IARC Sci Publ. 2007;IX.
    1. Rubin DB. Multiple Imputation for Nonresponse in Surveys (2nd edn). New York: John Wiley and Sons; 1987.
    1. Nur U, Shack LG, Rachet B, Carpenter JR, Coleman MP. Modelling relative survival in the presence of incomplete data: A tutorial. Int J Epidemiol. 2010;39:118–28. 10.1093/ije/dyp309
    1. StataCrop. STATA Statistical Software. College Station, TX: Stata Corporation, version 12, 2014. . Accessed July 15, 2014.
    1. Royston P. Multiple imputation of missing values: update. Stata J. 2005;5:188–201. .
    1. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for jointpoint regression with applications to cancer rates. Stat Med. 2000;19:335–51. 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>;2-Z
    1. Ito Y, Ioka A, Tanaka M, Nakayama T, Tsukuma H. Trends in cancer incidence and mortality in Osaka, Japan: Evaluation of cancer control activities. Cancer Sci. 2009;100(12):2390–5. 10.1111/j.1349-7006.2009.01311.x
    1. National Cancer Institute. Joinpoint Regresssion Program Ver. 4.1.0. 2014. . Accessed June 1, 2014.
    1. Sone S, Takashima S, Li F, Yang Z, Honda T, Maruyama Y, et al. . Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet. 1998;351(9111):1242–5. 10.1016/S0140-6736(97)08229-9
    1. Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R, et al. . Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association. J Clin Oncol. 2002;20(4):911–20. 10.1200/JCO.20.4.911
    1. Kris MG, Natale RB, Herbst RS, Lynch TJ Jr, Prager D, Belani CP, et al. . Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. JAMA. 2003;290(16):2149–58. 10.1001/jama.290.16.2149
    1. Sobue T, Yamamoto S, Hara M, Sasazuki S, Sasaki S, Tsugane S; JPHC Study Group; Japanese Public Health Center . Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: The JPHC study. Int J Cancer. 2002;99:245–51. 10.1002/ijc.10308
    1. Pesch B, Kendzia B, Gustavsson P, Jöckel KH, Johnen G, Pohlabeln H, et al. . Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case–control studies. Int J Cancer. 2012;131:1210–9. 10.1002/ijc.27339
    1. Ministry of Health, Labour and Welfare. Tobacco or health. Japanese Tobacco inc. Japan smoking rate survey (2014). . Accessed December 26, 2014.
    1. Marugame T, Kamo K, Sobue T, Akiba S, Mizuno S, Satoh H, et al. . Trends in smoking by birth cohorts born between 1900 and 1977 in Japan. Prev Med. 2006;42:120–7. 10.1016/j.ypmed.2005.09.009
    1. Ministry of Health, Labour and Welfare, Japan. Comprehensive Survey of Living Conditions. Prefectural Smoking Rate (2001, 2004, 2007, 2010 and 2013). . Accessed October 25, 2015.
    1. Nakamura H, Saji H. A worldwide trend of increasing primary adenocarcinoma of the lung. Surg Today. 2014;44:1004–12. 10.1007/s00595-013-0636-z
    1. Ito H, Matsuo K, Tanaka H, Koestler DC, Ombao H, Fulton J, et al. . Nonfilter and filter cigarette consumption and the incidence of lung cancer by histological type in Japan and the United States: analysis of 30-year data from population-based cancer registries. Int J Cancer. 2011;128:1918–28. 10.1002/ijc.25531
    1. Ministry of Health, Labour and Welfare. Tobacco or health. Tobacco institute of Japan. Data Concerning Tobacco. .
    1. Chen F, Bina WF, Cole P. Declining incidence rate of lung adenocarcinoma in the United States. Chest. 2007;131:1000–5. 10.1378/chest.06-1695
    1. Radzikowska E, Głaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol. 2002;13(7):1087–93. 10.1093/annonc/mdf187
    1. Toh CK, Gao F, Lim WT, Leong SS, Fong KW, Yap SP, et al. . Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol. 2006;24(15):2245–51. 10.1200/JCO.2005.04.8033
    1. Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba I, et al. . Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst. 2005;97(5):339–46. 10.1093/jnci/dji055
    1. World Health Organization. International Agency for Research on Cancer Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum. 2004;83:1431–8.
    1. Kurahashi N, Inoue M, Liu Y, Iwasaki M, Sasazuki S, Sobue T, et al. . Passive smoking and lung cancer in Japanese non-smoking women: a prospective study. Int J Cancer. 2008;122(3):653–7. 10.1002/ijc.23116
    1. Katanoda K, Sobue T, Satoh H, Tajima K, Suzuki T, Nakatsuka H, et al. . An association between long-term exposure to ambient air pollution and mortality from lung cancer and respiratory diseases in Japan. J Epidemiol. 2011;21(2):132–43. 10.2188/jea.JE20100098
    1. Chen F, Cole P, Bina WF. Time trend and geographic patterns of lung adenocarcinoma in the United States, 1973–2002. Cancer Epidemiol Biomarkers Prev. 2007;16(12):2724–9. 10.1158/1055-9965.EPI-07-0455
    1. Ministry of the Environment. Environmental Statistics 2014. Atmospheric Environment. . Accessed October 23, 2015.
    1. Lortet-Tieulent J, Soerjomataram I, Ferlay J, Rutherford M, Weiderpass E, Bray F. International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer. 2014;84(1):13–22. 10.1016/j.lungcan.2014.01.009
    1. Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, et al. . Smoking prevalence and cigarette consumption in 187 countries, 1980–2012. JAMA. 2014;311(2):183–92. 10.1001/jama.2013.284692
    1. Eriksen M, Mackay J, Schluger N, Gomeshtapeh FI, Drope J. American Cancer Society and World Lung Foundation. The Tobacco Atlas, Fifth Edition; 2015. .
    1. Au JS, Mang OW, Foo W, Law SC. Time trends of lung cancer incidence by histologic types and smoking prevalence in Hong Kong 1983–2000. Lung Cancer. 2004;45:143–52. 10.1016/j.lungcan.2004.01.012
    1. Kong J, Xu F, He M, Chen K, Qian B. The incidence of lung cancer by histological type: a population-based study in Tianjin, China during 1981–2005. Respirology. 2014;19(8):1222–8. 10.1111/resp.12373
    1. Ma GX, Lan Y, Toubbeh MI, Zhai C. Tobacco use in China: prevalence, consequences and control. Health Promot. 2004;2(1):107–19.
    1. World Health Organization. Global Adult Survey data. China. 2010. . Accessed April 29, 2015.
    1. Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods. 2002;7(2):147–77. 10.1037/1082-989X.7.2.147
    1. Cancer incidence in five continents Volumes I to X. Indices of data quality. IARC Sci Publ. I–X. . Accessed October 27, 2015.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться